AOS to take Misonix products to eastern Europe
This article was originally published in Clinica
Misonix has entered a two-year deal with private German firm Advanced Oncology Systems (AOS) to sell its ultrasonic technology in eastern Europe. The deal sees Wuppertal-based AOS make Misonix’s Sonablate SB500 high-intensity focused ultrasound (HIFU) system, SonaStar ultrasonic surgical aspiration system, BoneScalpel ultrasonic bone cutting system, and its SonicOne ultrasound cleansing and debridement system available in countries such as Hungary, Poland, Romania, Bulgaria, Russia, Ukraine and Georgia. Misonix (Farmingdale, New York) said that sales would be carried out by specialty distributors, while sales made directly to hospitals would be permitted in certain instances. Financial terms of the deal were not disclosed.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals